Upload
lighthouse-ip-group
View
125
Download
0
Tags:
Embed Size (px)
Citation preview
From information to understanding
Intelligent IP Monitoring
East meets WestVienna, 2012
Jane List, Lighthouse IP Group
Agenda
IntroductionChinese patents in English
Intelligent IP Monitoring
1 2 3 4 5 6 7 8 9 10 11 12 130
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000applications
grants
utility models
Chinese Publications January – March 2012
Translations teamspecialists in patent translation
Linguists, data and subject specialists
Statistical MT engine
IPC + dictionaries
Translation models
Segmentation
CN Patent documents
Chinese - English MT Translation Process
EN MT Patent documents
CN Patents & Utility Models
in English
Classifications
1985 to date
Inventors
Applicants
Legal Status Events
Inline ImagesTitle, AbstractDescription, Claims
7 - 10 days
China legal status events
Assignment of Patent Right (Article 10)Withdrawal of Application (Article 32,35-37)Publication of Application* (Article 34) Decision of Rejection (Article 38) Granted (Article 39)Termination (Article 42, 44)Abandonment (Article 44)Invalidation* (Article 45-47)
• 130 events human translated into English
• Available within 7- 10 days of publication
• Complete event history
Intelligent IP Monitoring
Search in English / Chinese
Full text of 5.3 m patents – Chinese / English MT
Search in English MT / Chinese Original
Translate into English
Analyse documents
Report
Competitive intelligence
CN Patent Watch
Market intelligence
Portfolio monitoring Technology tracking
Example: Monitoring applicant patent activity
Search name variantsChinese English
雀巢公司 Nestle Company
雀巢 Nestle
雀巢股份有限公司 Nestle SA
Review equivalents as they are published in Chinatrack legal status, obtain file history:
Anti-adhesive agent in relation to pathogenic flora of skin (PCT WO0145721 )EP priority - EP19990204489 22nd December 1999
CN 2000819148 Application date 13th December 2000CN 1434716 A Publication date 6th August 2003 / Granted 28th March 2012 CN 2008121653 Application date 13th December 2008CN 101385745 A Publication date 18th March 2009 / Granted 18th May 2011
Review documentsCinobufagin dry powder inhalant• medically acceptable auxiliary material, • Acts on lesions of the lung to reduce the
toxic and side effect
A Chinese dried toad venom• acceptable co-grinding material • directly acts on the lung infection,
reducing occurrence of sterilizing side side,
Example: identification of new pharmaceuticals for the treatment of cancer
本发明涉及干粉吸入剂,具体的说是一种脱氢蟾蜍色胺制成的干粉吸入剂、所述干粉吸入剂的制备方法和在制备治疗肺部肿瘤药物中的应用。一种脱氢蟾蜍色胺干粉吸入剂,其特征在于它是由脱氢蟾蜍色胺与医学上可接受的辅料组成,脱氢蟾蜍色胺与所述的辅料的质量比为 1 0.02-1 100∶ ∶ 。。
The invention relates to dry powder inhalation, is specific is dry powder and water of dehydrogenation toad tryptamine, wherein the dry powder inhalation and preparation method and application in preparing drug for treating lung cancer medicine
1,3,4,5-Tetrahydro-6-hydroxy-5,5-dimethylpyrrolo[4,3,2-de]quinolin-5-iumDehydrobufotenine
Intelligent IP Monitoring
• automated search by IPC or applicant
• search / review Chinese text• monitor an individual document• full service for Chinese, Japanese,
Russian, Thailand patents